Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8114
Reference
Drug alert 14/2024
Name
Drug alert class 3 – 14 2024 – Class 3 medicines defect information – action within 5 days – Neon Healthcare Ltd, Suprefact 1mg/ml solution for injection (Cheplapharm – Canadian livery)
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure. This is because the named batch of Suprefact 1mg/ml solution for injection is being distributed in packaging intended for the Canadian market by Cheplapharm, instead of the correct UK packaging by Neon Healthcare Ltd for Buserelin 1 mg/ml solution for injection.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-04-23 15:39:35
Click to go back to homepage